It is crucial to understand that while a link was observed in animal studies, it is not yet established whether GLP-1 medications cause MTC in humans
Self-funded employer plans (where the employer pays claims directly and contracts with an insurer for administration) have wide latitude to include or exclude obesity medications
The request is not for the continuation of therapy, and
Metoclopramide may be considered for short-term use only (generally less than 12 weeks) due to the risk of tardive dyskinesia with prolonged use
On average, the drug has a half-life of about 19 to 24 hours , which means it takes roughly that amount of time for half of the drug to be cleared from your bloodstream
In both comparisons, adults taking GLP-1 drugs were associated with a significantly higher risk of hair loss, more specifically, 37 percent higher compared to SGLT-2 inhibitors and 68 percent higher than DPP-4 inhibitors